Asia Pacific Intravenous Infusion Pumps Market Size, Share, and COVID-19 Impact Analysis, By Product (Volumetric Infusion Pumps, Syringe Infusion Pumps, and Others), By Disease Indication (Chemotherapy, Diabetes, Gastroenterology, Paediatrics/Neonatology, and Others), and Asia Pacific Intravenous Infusion Pumps Market Insights, Industry Trend, Forecasts to 2035

Asia Pacific Intravenous Infusion Pumps Market Insights Forecasts to 2035

• The Asia Pacific Intravenous Infusion Pumps Market Size was Estimated at USD 995.5 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.53% from 2025 to 2035
• The Asia Pacific Intravenous Infusion Pumps Market Size is Expected to Reach USD 2450.5 Million by 2035

The Asia Pacific Intravenous Infusion Pumps Market Size is anticipated to Reach USD 2450.5 Million by 2035, Growing at a CAGR of 8.53% from 2025 to 2035. The increasing need for accurate administration of medications & therapies owing to the growing prevalence of cancer, diabetes, cardiovascular, and respiratory illnesses is driving the intravenous infusion pumps market in the Asia Pacific region.

Market Overview

The Asia Pacific Intravenous Infusion Pumps Market Size is an industry that focuses on the development, manufacturing, and sale of medical devices used for delivering fluids, medications, and nutrients into a patients bloodstream at a controlled rate. An intravenous infusion pump is a device used for administering medication or medication used for treating high blood pressure. With an increase in chronic disease prevalence, demand for infusion pumps is expanding for effective disease management. Technological advancements in smart, interconnected, and automated systems lead to the optimisation of the precision and safety of infusion therapy. Further, advanced infusion management solutions are in high demand. Innovative medical technologies, along with ongoing infrastructural enhancements in the healthcare facilities, are providing market growth opportunities for intravenous infusion pumps.

Report Coverage

This research report categorizes the market for the Asia Pacific intravenous infusion pumps market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific intravenous infusion pumps market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific intravenous infusion pumps market.

Driving Factors

Intravenous infusion pumps are crucial for the accurate and controlled administration of medications and therapies, delivering fluids, such as medications and nutrients, at a precise rate and volume, in order to minimise the risk associated with manual fluid administration. The increasing prevalence of chronic diseases, rising geriatric demographic, along with an increasing number of surgical procedures, are driving the demand for advanced infusion management solutions, thereby escalating the market growth. In addition, the rapid technological advancement in the development of smart, connected, automated pumps is propelling the market growth for intravenous infusion pumps.

Restraining Factors

The threat of infection complications associated with IV therapy is limiting the market growth for intravenous infusion pumps. Further, the increased cost and maintenance expenses, as well as strict regulations, are hampering the market growth.

Market Segmentation

The Asia Pacific intravenous infusion pumps market share is classified into product and disease indication.

• The volumetric infusion pumps segment held the dominant market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific intravenous infusion pumps market is segmented by product into volumetric infusion pumps, syringe infusion pumps, and others. Among these, the volumetric infusion pumps segment held the dominant market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Volumetric infusion pumps are used for delivering parenteral nutrition, blood products, and other intravenous fluid products in a safe and precise manner. Further, the integration of advanced technologies and drug libraries by the key market players for enhancing efficiency is propelling the market growth.

• The paediatrics/neonatology segment dominated the intravenous infusion pumps market in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific intravenous infusion pumps market is segmented by disease indication into chemotherapy, diabetes, gastroenterology, paediatrics/neonatology, and others. Among these, the paediatrics/neonatology segment dominated the intravenous infusion pumps market in 2024 and is expected to grow at a significant CAGR during the forecast period. As per the CDC report, 1 in every 33 babies born in the US is diagnosed with a congenital disability each year. The emergence of modern infusion pumps for measuring inline intravenous pressure is contributing to driving market growth in the paediatrics/neonatology segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific intravenous infusion pumps market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Becton, Dickinson and Company (BD)
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Baxter International, Inc.
• Medtronic PLC
• ICU Medical, Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific Intravenous Infusion Pumps Market based on the below-mentioned segments:

Asia Pacific Intravenous Infusion Pumps Market, By Product

• Volumetric Infusion Pumps
• Syringe Infusion Pumps
• Others

Asia Pacific Intravenous Infusion Pumps Market, By Disease Indication

• Chemotherapy
• Diabetes
• Gastroenterology
• Paediatrics/Neonatology
• Others